July 6, 2022--Researched by Industrial Info Resources (Sugar Land, Texas)--The New England market region, which includes Connecticut, Massachusetts, Maine, New Hampshire, Rhode Island and Vermont, has long been a hotspot for the Pharmaceutical-Biotech Industry and continues to hold this status. Of the more than $19.6 billion in industrial projects under construction in the region, Pharma-Biotech accounts for more than $10.4 billion worth. This is followed by the Industrial Manufacturing and Power industries. Companies featured: <a href='https://www.bms.com/' target='_blank'>Bristol-Meyers Squibb Company</a> (<a href='https://www.nyse.com/quote/XNYS:BMY' target='_blank'>NYSE:BMY</a>), <a href='https://www.gd.com/' target='_blank'>General Dynamics Corporation</a> (<a href='https://www.nyse.com/quote/XNYS:GD' target='_blank'>NYSE:GD</a>), <a href='https://www.jacobs.com/' target='_blank'>Jacobs Engineering Incorporated</a> (<a href='https://www.nyse.com/quote/XNYS:J' target='_blank'>NYSE:J</a>), <a href='https://www.entergy.com/' target='_blank'>Entergy Corporation</a> (<a href='https://www.nyse.com/quote/XNYS:ETR' target='_blank'>NYSE:ETR</a>)
